Terazosin for energy in ALS patients
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether a medication called terazosin can boost energy levels in people with ALS (Lou Gehrig's disease). The goal is to see if it helps slow down the disease by supporting cell energy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You need a doctor's diagnosis of ALS (Lou Gehrig's disease).
- Your ALS symptoms must have started within the last 3 years.
- You must be able to swallow pills.
- You must not be taking blood thinners (like warfarin or Eliquis).
- You must not have diabetes or high blood sugar levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called tazbentetol for people with ALS (amyotrophic lateral sclerosis), a disease that affects nerve cells controlling muscles. The goal is to see if it is safe and effective, and it may help slow the progression of the disease.
This study tests a supplement called acetyl-L-carnitine (ALCAR) to see if it can slow the progression of ALS. It is for people in the early stages of the disease who are already taking riluzole and have good lung and muscle function.
This trial tests whether an experimental drug called tideglusib can slow the progression of ALS. It is for people with a recent ALS diagnosis whose breathing is still fairly strong.
This trial tests a medication called darifenacin (usually used for bladder problems) in people with ALS, to see if it is safe and if it might help slow the disease. If you join, you will take the study drug or a placebo and be closely monitored.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests a new drug called VTx-002 to see if it is safe and tolerable for people with ALS. You may be able to join if you have had symptoms for less than 18 months and have a caregiver who can help.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.